A detailed history of Vantage Consulting Group Inc transactions in Viatris Inc stock. As of the latest transaction made, Vantage Consulting Group Inc holds 22,913 shares of VTRS stock, worth $262,812. This represents 0.4% of its overall portfolio holdings.

Number of Shares
22,913
Previous 19,383 18.21%
Holding current value
$262,812
Previous $231,000 5.19%
% of portfolio
0.4%
Previous 0.34%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $35,476 - $42,430
3,530 Added 18.21%
22,913 $243,000
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $49,959 - $59,978
-4,433 Reduced 18.61%
19,383 $231,000
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $7,770 - $9,613
886 Added 3.86%
23,816 $257,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $16,005 - $18,943
-1,669 Reduced 6.78%
22,930 $226,000
Q2 2023

Aug 11, 2023

BUY
$9.02 - $10.29 $5,565 - $6,348
617 Added 2.57%
24,599 $245,000
Q1 2023

May 10, 2023

BUY
$9.2 - $12.26 $14,177 - $18,892
1,541 Added 6.87%
23,982 $230,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $31,051 - $41,165
-3,561 Reduced 13.7%
22,441 $249,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $38,541 - $50,585
4,545 Added 21.18%
26,002 $222,000
Q2 2022

Aug 09, 2022

SELL
$9.95 - $12.27 $14,437 - $17,803
-1,451 Reduced 6.33%
21,457 $225,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $23,975 - $37,637
2,444 Added 11.94%
22,908 $249,000
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $34,746 - $42,190
2,874 Added 16.34%
20,464 $277,000
Q3 2021

Nov 10, 2021

BUY
$13.25 - $15.13 $42,135 - $48,113
3,180 Added 22.07%
17,590 $238,000
Q2 2021

Aug 11, 2021

BUY
$12.97 - $16.15 $34,059 - $42,409
2,626 Added 22.28%
14,410 $206,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $22,831 - $31,147
-1,680 Reduced 12.48%
11,784 $165,000
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $192,535 - $252,315
13,464 New
13,464 $252,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Vantage Consulting Group Inc Portfolio

Follow Vantage Consulting Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Consulting Group Inc with notifications on news.